Dietary Influence on Pancreatic Cancer Growth by Catechin and Inositol Hexaphosphate

Journal of Surgical Research

Volumn 141, Issue 1, 2007, Pages 115-119

  McMillan, Brian ^a   Riggs, Dale R ^a   Jackson, Barbara J ^a   Cunningham, Cynthia ^a   McFadden, David W ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

apoptosis; catechin; inositol hexaphosphate; pancreatic cancer; VEGF

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CATECHIN; FLUORESCEIN ISOTHIOCYANATE; LIPOCORTIN 5; PHYTIC ACID; VASCULOTROPIN;

APOPTOSIS; ARTICLE; CANCER GROWTH; CELL CULTURE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DIET; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; PANCREAS CANCER; PRIORITY JOURNAL; SUPERNATANT;

APOPTOSIS; CATECHIN; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DRUG SYNERGISM; HUMANS; NECROSIS; PANCREATIC NEOPLASMS; PHYTIC ACID; TETRAZOLIUM SALTS; THIAZOLES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34250162505     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2007.03.065     Document Type: Article

References (14)

1. Jemal A., Siegel R., Ward E., et al. Cancer Statistics, 2007. CA Cancer J Clin 57 (2007) 43
2. Somasundar P., Riggs D.R., Jackson B.J., et al. Inositol hexaphosphate (IP6): A novel treatment for pancreatic cancer. J Surg Res 126 (2005) 199
3. Singh R.P., Sharma G., Mallikarjuna G.U., et al. In vivo suppression of hormone-refractory prostate cancer growth by inositol hexaphosphate: Induction of insulin-like growth factor binding protein-3 and inhibition of vascular endothelial growth factor. Clin Cancer Res 10 (2004) 244
4. Agarwal C., Dhanalakshmi S., Singh R.P., et al. Inositol hexaphosphate inhibits constitutive activation of NF-kappa B in androgen-independent human prostate carcinoma DU145 cells. Anticancer Res 23 (2003) 3855
5. Tantivejkul K., Vucenik I., and Shamsuddin A.M. Inositol hexaphosphate (IP6) inhibits key events of cancer metastasis: II. Effects on integrins and focal adhesions. Anticancer Res 23 (2003) 3681
6. Shamsuddin A.M., Elsayed A.M., and Ullah A. Suppression of large intestinal cancer in F344 rats by inositol hexaphosphate. Carcinogenesis 9 (1988) 577
7. Mohseni H.F., Kandzari S.J., Zaslau S., et al. Synergistic effects of Cox 1 and 2 inhibition on bladder and prostate in vitro. Am J Surg 188 (2004) 505
8. McFadden D.W., Riggs D.R., Jackson B.J., et al. Additive effects of Cox-1 and Cox-2 inhibition on breast cancer in vitro. Int J Oncol 29 (2006) 1019
9. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65 (1983) 55
10. Dixon W.J., and Massey F.J. Introduction to Statistical Analysis. 4th ed. (1983), McGraw-Hill, New York
11. Ludbrook J. Multiple comparison procedures updated. Clin Exp Pharmacol Physiol 25 (1998) 1032
12. Vucenik I., Passaniti A., Vitolo M.I., et al. Anti-angiogenic activity of inositol hexaphosphate (IP6). Carcinogenesis 26 (2004) 2115
13. Chow H.H., Cai Y., Alberts D.S., et al. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. Cancer Epidemio1 Biomarkers Prev 10 (2001) 53
14. Yang C.S., Maliakal P., and Meng X. Inhibition of carcinogenesis by tea. Annu Rev Pharmacol Toxicol 42 (2002) 25